Comprehensive family therapy: An effective approach for cognitive rehabilitation in schizophrenia

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 1247-1253

  Cai, Jun ^a   Zhu, Yi ^a   Zhang, Weibo ^a   Wang, Yanfeng ^a   Zhang, Chen ^b  

^a SHANGHAI MENTAL HEALTH CENTER   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cognitive function; Comprehensive family therapy; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; CHINA; CLINICAL EFFECTIVENESS; COGNITIVE REHABILITATION; COMPREHENSIVE FAMILY THERAPY; CONTROLLED STUDY; DEPTH PERCEPTION; FAMILY THERAPY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTICENTER STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84930505884     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S83569     Document Type: Article

References (30)

1. Zhang C, Li Z, Shao Y, et al. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci. 2011;43(3):406–411.
2. Long J, Huang G, Liang W, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244–256.
3. Paquin K, Wilson AL, Cellard C, Lecomte T, Potvin S. A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning? BMC Psychiatry. 2014;14:139.
4. Keefe RS, Harvey PD. Cognitive impairment in schizophrenia. Handb Exp Pharmacol. 2012;(213):11–37.
5. Lu W, Zhang C, Yi Z, Li Z, Wu Z, Fang Y. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia. J Mol Neurosci. 2012;47(3):505–510.
6. Zhang C, Cai J, Zhang J, et al. Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:110–115.
7. Elvevåg B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol. 2000;14(1):1–21.
8. Zhang C, Fang Y, Xu L. Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments. Schizophr Res. 2014;159(2–3):376–384.
9. Marder SR, Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004;72(1):5–9.
10. Shimizu S, Mizuguchi Y, Ohno Y. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions. CNS Neurol Disord Drug Targets. 2013;12(6):861–869.
11. Cai J, Yi Z, Lu W, Fang Y, Zhang C. Crosstalk between 5-HT2cR and PTEN signaling pathway in atypical antipsychotic-induced metabolic syndrome and cognitive dysfunction. Med Hypotheses. 2013;80(4):486–489.
12. Genevsky A, Garrett CT, Alexander PP, Vinogradov S. Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues Clin Neurosci. 2010;12(3):416–421.
13. Dang J, Zhang J, Guo Z, et al. A pilot study of iPad-assisted cognitive training for schizophrenia. Arch Psychiatr Nurs. 2014;28(3):197–199.
14. Roberts DL, Penn DL. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res. 2009;166(2–3):141–147.
15. Bowie CR, McGurk SR, Mausbach B, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry. 2012;169(7):710–718.
16. Friedman-Yakoobian MS, Mueser KT, Giuliano A, Goff DC, Seidman LJ. Family-directed cognitive adaptation for schizophrenia. J Clin Psychol. 2009;65(8):854–867.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
18. Cheng Y, Wu W, Feng W, et al. The effects of multi-domain versus single-domain cognitive training in non-demented older people: a randomized controlled trial. BMC Med. 2012;10:30.
19. Liberman RP, Wallace CJ, Blackwell G, Kopelowicz A, Vaccaro JV, Mintz J. Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry. 1998;155(8):1087–1091.
20. Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310–319.
21. Zhu Y, Wang Z, Ni J, et al. Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese. J Hum Genet. 2015;60(1):11–16.
22. Pinkham AE. Social cognition in schizophrenia. J Clin Psychiatry. 2014;75 Suppl 2:14–19.
23. Bucci P, Piegari G, Mucci A, et al. Neurocognitive individualized training versus social skills individualized training: a randomized trial in patients with schizophrenia. Schizophr Res. 2013;150(1):69–75.
24. Cohen AN, Glynn SM, Murray-Swank AB, et al. The family forum: directions for the implementation of family psychoeducation for severe mental illness. Psychiatr Serv. 2008;59(1):40–48.
25. Ozkan B, Erdem E, Demirel Ozsoy S, Zararsiz G. Effect of psychoeducation and telepsychiatric follow up given to the caregiver of the schizophrenic patient on family burden, depression and expression of emotion. Pak J Med Sci. 2013;29(5):1122–1127.
26. Chien WT, Chan SW. The effectiveness of mutual support group intervention for Chinese families of people with schizophrenia: a randomised controlled trial with 24-month follow-up. Int J Nurs Stud. 2013;50(10):1326–1340.
27. Guo X, Zhai J, Liu Z, et al. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study. Arch Gen Psychiatry. 2010;67(9):895–904.
28. Pontes LM, Martins CB, Napolitano IC, et al. Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil. Schizophr Res Treatment. 2013;2013:321725.
29. Han M, Zhang XY, Chen da C, et al. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics. Int Clin Psychopharmacol. 2015;30(2):89–95.
30. Beninger RJ, Baker TW, Florczynski MM, Banasikowski TJ. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Neurotox Res. 2010;18(3–4):229–243.